Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Elimination of Health Disparities Through Translation Research (Panel C), Funding Opportunity Announcement (FOA), CD08-001, 36518 [E8-14580]
Download as PDF
36518
Federal Register / Vol. 73, No. 125 / Friday, June 27, 2008 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
No. of
respondents
No. of responses
per respondent
Average burden
per response
(in hours)
Regulation
Respondent
42 CFR 70.3 Application to the State of Destination
for a permit.
Traveler ............................
2,000
1
15/60
Attending physician ..........
State health authority .......
2,000
8
1
250
15/60
6/60
Master of a vessel or person in charge of conveyance.
1,500
1
15/60
State health authority .......
20
75
6/60
Traveler ............................
3,750
1
15/60
Attending physician ..........
3,750
1
15/60
42 CFR 70.3 Copy of material submitted by applicant and permit issued by State health authority.
42 CFR 70.4 Report by the master of a vessel or
person in charge of conveyance of the incidence
of a communicable disease occurring while in
interstate travel.
42 CFR 70.4 Copy of material submitted or State
or local health authority under this provision.
42 CFR 70.5 Application for a permit to move from
State to State while in the communicable period.
Dated: June 20, 2008.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–14589 Filed 6–26–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jlentini on PROD1PC65 with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Elimination of
Health Disparities Through Translation
Research (Panel C), Funding
Opportunity Announcement (FOA),
CD08–001
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10 a.m.–5 p.m., July
16, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Elimination of Health
Disparities through Translation
Research (Panel C), FOA CD08–001.’’
Contact Person for More Information:
Susan B. Stanton, D.D.S., Scientific
Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone (404)
639–4640.
VerDate Aug<31>2005
18:47 Jun 26, 2008
Jkt 214001
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: June 20, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–14580 Filed 6–26–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Elimination of
Health Disparities through Translation
Research (Panel B), Funding
Opportunity Announcement (FOA),
CD08–001
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10 a.m.–5 p.m., July
15, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review, discussion, and
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
evaluation of ‘‘Elimination of Health
Disparities through Translation
Research (Panel B), FOA CD08–001.’’
Contact Person for More Information:
Susan B. Stanton, D.D.S., Scientific
Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone (404)
639–4640.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: June 20, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–14587 Filed 6–26–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare and Medicaid
Services
[CMS–2898–PN]
Medicare and Medicaid Programs; The
Joint Commission for Continued
Deeming Authority for Ambulatory
Surgical Centers
Centers for Medicare and
Medicaid Services, HHS.
ACTION: Proposed notice.
AGENCY:
SUMMARY: This proposed notice
acknowledges the receipt of a deeming
application from the Joint Commission
for continued recognition as a national
accrediting organization for ambulatory
surgical centers (ASCs) that wish to
E:\FR\FM\27JNN1.SGM
27JNN1
Agencies
[Federal Register Volume 73, Number 125 (Friday, June 27, 2008)]
[Notices]
[Page 36518]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14580]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Elimination of Health Disparities Through
Translation Research (Panel C), Funding Opportunity Announcement (FOA),
CD08-001
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 10 a.m.-5 p.m., July 16, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of ``Elimination of Health Disparities
through Translation Research (Panel C), FOA CD08-001.''
Contact Person for More Information: Susan B. Stanton, D.D.S.,
Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop
D72, Atlanta, GA 30333, Telephone (404) 639-4640.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: June 20, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-14580 Filed 6-26-08; 8:45 am]
BILLING CODE 4163-18-P